Companies /Healthcare

Acadia Pharmaceuticals Inc

NASDAQ: ACAD Biotechnology
$17.11
▼ $0.48 (−2.73%) today
Markets closed · 5:33am ET

ACAD Coverage Page 3

9:40am ET
Health and Healthcare

Why This New Dementia Study Is a Huge Hit

Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.

Chris Lange